Towa Prevails in IP High Court Ruling for Livalo Damage Suit, Kowa Mulls Next Step

September 22, 2022
Generic maker Towa Pharmaceutical said on September 21 that the Intellectual Property High Court ruled in its favor the same day in a damage lawsuit over the hyperlipidemia treatment Livalo OD Tablets (pitavastatin), which had been filed by the drug’s...read more